Researchers from the Butantan Institute in São Paulo are working on developing a product made from antibodies of recovered Covid-19 patients to help combat the diseases. These so-called “neutralizing monoclonal antibodies” are extracted from the blood plasma of people who have been cured of the virus, and the idea is that the proteins may be used to latch on to Covid-19 strains and neutralize them.
The project is part of a larger initiative to create monoclonal antibodies to fight a number of different diseases, having already reached advanced development stages to combat zika and tetanus.
There are over 70 pharmaceutical products available for clinical use around the world that contain monoclonal antibodies, used to fight diseases such as ebola and cancer. The hope is that this could be a potential treatment for Covid-19, but lead researcher Ana Maria Moro admits that “it will be a long process.”
The specialization trend among corporate board members It is not only a matter of perception:…
Panama will hold its presidential elections on Sunday, months after huge protests saw thousands descend…
The city of Rio de Janeiro estimates that a Madonna concert this Saturday on Copacabana…
Latin America’s trend of banning opposition candidates from elections has caught on in an ever-growing…
The São Paulo City Council on Thursday approved legislation authorizing Brazil’s largest city to sign…
The preliminary report on AI regulations presented to Brazil’s Senate last week provides a middle-of-the-road…